Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
1.730
-0.230 (-11.73%)
Oct 3, 2025, 4:00 PM EDT - Market closed
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $45.01 million as of October 3, 2025. Its market cap has decreased by -69.39% in one year.
Market Cap
45.01M
Enterprise Value
64.92M
1-Year Change
-69.39%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $45.01M, a decrease of -86.99%. That is a compound annual growth rate of -37.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 45.01M | -43.81% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |